We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Augmedix (AUGX) This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Augmedix, Inc. (AUGX - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Augmedix, Inc. is one of 1110 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Augmedix, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AUGX's full-year earnings has moved 4% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, AUGX has gained about 214.1% so far this year. At the same time, Medical stocks have lost an average of 3.4%. This shows that Augmedix, Inc. is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Intuitive Surgical, Inc. (ISRG - Free Report) . The stock is up 13.9% year-to-date.
The consensus estimate for Intuitive Surgical, Inc.'s current year EPS has increased 5.3% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, Augmedix, Inc. belongs to the Medical Info Systems industry, which includes 43 individual stocks and currently sits at #99 in the Zacks Industry Rank. Stocks in this group have gained about 26% so far this year, so AUGX is performing better this group in terms of year-to-date returns.
On the other hand, Intuitive Surgical, Inc. belongs to the Medical - Instruments industry. This 95-stock industry is currently ranked #108. The industry has moved -4% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to Augmedix, Inc. and Intuitive Surgical, Inc. as they could maintain their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Augmedix (AUGX) This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Augmedix, Inc. (AUGX - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Augmedix, Inc. is one of 1110 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Augmedix, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AUGX's full-year earnings has moved 4% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, AUGX has gained about 214.1% so far this year. At the same time, Medical stocks have lost an average of 3.4%. This shows that Augmedix, Inc. is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Intuitive Surgical, Inc. (ISRG - Free Report) . The stock is up 13.9% year-to-date.
The consensus estimate for Intuitive Surgical, Inc.'s current year EPS has increased 5.3% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, Augmedix, Inc. belongs to the Medical Info Systems industry, which includes 43 individual stocks and currently sits at #99 in the Zacks Industry Rank. Stocks in this group have gained about 26% so far this year, so AUGX is performing better this group in terms of year-to-date returns.
On the other hand, Intuitive Surgical, Inc. belongs to the Medical - Instruments industry. This 95-stock industry is currently ranked #108. The industry has moved -4% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to Augmedix, Inc. and Intuitive Surgical, Inc. as they could maintain their solid performance.